Nebula Research & Development’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-14,145
Closed -$560K 929
2024
Q2
$560K Buy
+14,145
New +$458K 0.09% 395
2023
Q4
Sell
-7,942
Closed -$249K 641
2023
Q3
$249K Sell
7,942
-5,292
-40% -$166K 0.13% 333
2023
Q2
$419K Buy
+13,234
New +$428K 0.32% 163

Other funds holding ATEX

Nebula Research & Development's ATEX Position: Q3 2024 in Review

Nebula Research & Development sold out of Anterix (ATEX) in Q3 2024, closing a stake of 14,145 shares — an estimated $560K sold.

Nebula Research & Development first reported a position in ATEX in Q2 2023 and held it in 3 quarters. The position peaked at $560K in Q2 2024. 129 funds tracked by Wall St. Rank hold ATEX as of Q3 2024.

  • Nebula Research & Development reported no remaining Anterix position as of Q3 2024 after selling out during the quarter.
  • Nebula Research & Development sold 14,145 Anterix shares in Q3 2024, an estimated $560K.
  • Nebula Research & Development first reported a position in Anterix in Q2 2023 and held it in 3 quarters.
  • Nebula Research & Development's Anterix position peaked at $560K in Q2 2024.
  • 129 funds tracked by Wall St. Rank held Anterix as of Q3 2024.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.